Construction and characterization of region-specific microdissection libraries and single-copy microclones for short arm of human chromosome 2

Jingwei Yu,S. Tong,J. Qi,F. Kao

DOI: https://doi.org/10.1007/BF02254724

1994-07-01

Somatic Cell Genetics

Abstract:

What problem does this paper attempt to address?

A case of epidermolysis bullosa acquisita with unusual clinical features

K Furukita,S Ansai,Y Hida,Y Kubo,S Arase,T Hashimoto

DOI: https://doi.org/10.1111/j.1365-2230.2009.03436.x

Abstract:A 30-year-old woman developed epidermolysis bullosa acquisita (EBA) with unusual clinical features. Initially, only prurigo-like nodules were seen, which lasted for > 2 years and then blisters appeared. Eruptions resembling the rash in systemic lupus erythematosus were also seen on the face. Histopathological examination of a biopsy specimen revealed subepidermal blisters containing eosinophils and neutrophils. Direct immunofluorescence examination, indirect immunofluorescence examination using skin split with 1 mol/L sodium chloride, and immunoblotting analysis using extracts of normal human dermis gave results compatible with EBA. This case shows that EBA can present with nodular lesions as seen in pemphigoid nodularis or epidermolysis bullosa pruriginosa.
Enabling Workflow-Aware Scheduling on HPC Systems

G. P. R. Álvarez,E. Elmroth,Per-Olov Östberg,L. Ramakrishnan

DOI: https://doi.org/10.1145/3078597.3078604

2017-06-26

Abstract:Scientific workflows are increasingly common in the workloads of current High Performance Computing (HPC) systems. However, HPC schedulers do not incorporate workflow-specific mechanisms beyond the capacity to declare dependencies between their jobs. Thus, workflows are run as sets of batch jobs with dependencies, which induces long intermediate wait times and, consequently, long workflow turnaround times. Alternatively, to reduce their turnaround time, workflows may be submitted as single pilot jobs that are allocated their maximum required resources for their entire runtime. Pilot jobs achieve shorter turnaround times but reduce the HPC system's utilization because resources may idle during the workflow's execution. We present a workflow-aware scheduling (WoAS) system that enables existing scheduling algorithms to exploit fine-grained information on a workflow's resource requirements and structure without modification. The current implementation of WoAS is integrated into Slurm, a widely used HPC batch scheduler. We evaluate the system using a simulator using real and synthetic workflows and a synthetic baseline workload that captures job patterns observed over three years of workload data from Edison, a large supercomputer hosted at the National Energy Research Scientific Computing Center. Our results show that WoAS reduces workflow turnaround times and improves system utilization without significantly slowing down conventional jobs.
Brief clinical report on visual reinforcement audiometry with deaf infants.

F. Rudmin

1984-12-01

The Journal of Otolaryngology

Abstract:Visual reinforcement audiometry (VRA) is a commonly used and efficient procedure for measuring hearing thresholds on infants and young children. The reliability of VRA with normal infants is well established. However, there are few reports, if any, in the literature on the use of VRA with deaf infants under one year of age. This report presents two cases of deaf 11 month old infants, showing test-retest audiograms obtained using VRA. The median retest threshold change was 10 dB. This suggests that VRA is a clinically viable technique, even with deaf infants.
Resident performance and sleep deprivation: a review.

M. Asken,D. Raham

DOI: https://doi.org/10.1097/00001888-198305000-00003

1983-05-01

Journal of Medical Education

Abstract:The literature on resident performance and sleep deprivation is reviewed. It is suggested that despite the urgent need for definitive work in the area, current research is sparse and inconclusive. It also is suggested that the research that does exist implies there are potentially severe negative effects from sleep deprivation on physicians-in-training. The present authors believe that justifications for sleep-depriving night call schedules remain untested and that the presence of sleep-depriving night call as part of residency training should be reevaluated.
Childhood epidermolysis bullosa acquisita: Confirmation of diagnosis by skin deficient in Type VII Collagen, enzyme-linked immunosorbent assay, and immunoblotting

Nupur Goyal,Raghavendra Rao,C Balachandran,Sathish Pai,Balbir S Bhogal,Enno Schmidt,Detlef Zillikens,BalbirS Bhogal

DOI: https://doi.org/10.4103/0019-5154.182420

2016-01-01

Indian Journal of Dermatology

Abstract:Epidermolysis bullosa acquisita (EBA) is an acquired subepidermal bullous disorder characterized by autoantibodies against Type VII collagen. It usually affects adults; childhood EBA is rare. We describe a 10-year-old girl presenting with recurrent tense blisters predominantly on legs, dorsa of hands and feet accompanied by oral erosions since the age of 5 years. Direct immunofluorescence (IF) microscopy showed linear deposition of IgG and C3 along the basement membrane zone (BMZ); indirect IF microscopy on salt-split skin revealed staining of IgG to the dermal side of the split. The patient's serum did not show BMZ staining in recessive dystrophic epidermolysis bullosa skin deficient for Type VII collagen, thus confirming autoantibody reactivity against Type VII collagen. Circulating antibodies against the immunodominant noncollagenous 1 domain of Type VII collagen were detected by ELISA and immunoblotting studies. The patient was treated with oral corticosteroids and dapsone with good improvement.

dermatology
[Acquired epidermolysis bullosa with a highly varied clinical picture and successful treatment with mycophenolate mofetil]

D Trebing,A Ziemer

DOI: https://doi.org/10.1007/s001050170089

Abstract:A 60-year-old woman with epidermolysis bullosa acquisita (EBA) presented with a highly variable clinical picture. First she developed oral erosions and ulcers covered with shaggy epithelial rests. Later she developed pustular and target lesions as well as tense cutaneous blisters. Clinically the alterations were strongly suggestive of aphthae or a pustular dermatosis. Histological and immunological examinations revealed subepidermal blister formation, neutrophilic infiltration, linear deposition of IgG and C3 at the basement membrane in the direct immunofluorescence and the evidence of circulating IgG-antibodies against basement membrane (monkey esophagus) in the indirect immunofluorescence. Thus our working diagnosis was a pustular or nodular form of bullous pemphigoid, as a linear IgA dermatosis was excluded. Indirect immunofluorescence using NaCl-separated primate skin localized the basement membrane antibodies in the base of the artificial blister, while immunoblotting of dermal extracts disclosed binding of serum antibodies to a 290-kDa protein. Bullous systemic lupus erythematosus was excluded, leading to the definitive diagnosis of EBA. The clinical variability of this disease is well known; the polymorphic picture in our patient with erosions, pustules, target lesions and blisters is unique in the literature. The similarity in histology and immunofluorescence of the clinically quite different lesions is another unexpected event. Also the speedy response to therapy with the immunosuppressive agent mycophenolate mofetil has only been described once before. The patient remains in remission after 6 months. Because of the poor response to therapy in most cases, the significant skin lesions are a source of physical as well as emotional distress. Additional complications include stenosis of trachea or bronchi injure.
Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen

D T Woodley,R E Burgeson,G Lunstrum,L Bruckner-Tuderman,M J Reese,R A Briggaman

DOI: https://doi.org/10.1172/JCI113373

Abstract:Epidermolysis bullosa acquisita (EBA) is a severe, chronic blistering disease of the skin. EBA patients have circulating and tissue-bound autoantibodies to a large (Mr = 290,000) macromolecule that is localized within the basement membrane zone between the epidermis and dermis of skin, the site of blister formation. The "EBA antigen" is known to be distinct from laminin, heparan sulfate proteoglycan, fibronectin, the bullous pemphigoid antigen, elastin, and collagen types I, II, III, IV, and V. Sera from patients with EBA, two monoclonal antibodies to the EBA antigen, and a monoclonal antibody to the carboxyl terminus of type VII procollagen identically label human amnion and skin by immunofluorescent and immunoelectron microscopy. Western immunoblots of the EBA antigen extracted from skin and of type VII procollagen labeled with the above sera and antibodies are identical. None of the sera or antibodies labels Western blots of pepsinized type VII collagen which is missing the globular amino and carboxyl terminal domains. These data show that the EBA antigen is the carboxyl terminus of type VII procollagen.
Generalized epidermolysis bullosa acquisita

Yan LI,Xi-xue CHEN,Xue-jun ZHU

DOI: https://doi.org/10.3969/j.issn.1000-4963.2009.11.012

2009-01-01

Abstract:Two eases of generalized epidermolysis bullosa aequisita (EBA) are reported. These two patients presented with widespread tense blisters after they were 40 years old. Salt-split skin indirect immunoflurescence and histopathology examina- tion could separate EBA from bullous pemphigoid.
[Clinical, histopathologic, immunofluorescent and ultrastructural estimation of 2 cases of epidermolysis bullosa acquisita]

B Lecewicz-Toruń,M Chibowska,D Chibowski,Z Siezieniewska

Abstract:Two cases of EBA were presented. Both patients with the symptoms of the disease were previously treated with nonsteroid antiinflammatory drugs. A considerable improvement of the patients condition has been noticed after the application of high doses of glucocorticosteroids. However, there were observed symptoms of a mild post-steroidal diabetes. In the histologically examined biopsies from lesions and from skin without any clinical changes were found subepidermal bulla containing serous fluid, erythrocytes and neutral granulocytes. At the patient no. 1 there were found linear deposits of IgG and fraction of C3 complement in the structure of a basal membrane. Ultrastructural research showed in both cases presence of subepidermal bulla located beneath lamina densa of a basal membrane. In the place of bulla there was observed a visible damage of anchoring fibres and collagen of a papillary layer of inner skin.
Identification of proteins in leaf tissues of white clover using MALDI-TOF mass spectrometry

Z. Du,M. McManus

DOI: https://doi.org/10.1007/s10535-011-0037-3

2011-04-30

Biologia Plantarum

Abstract:
Versatile trifunctional chemosensor of rhodamine derivative for Zn2+, Cu2+ and His/Cys in aqueous solution and living cells.

Lin Xu,Yufang Xu,Weiping Zhu,Bu-Bing Zeng,Chu‐Ting Yang,Binghan Wu,X. Qian

DOI: https://doi.org/10.1039/c1ob06025b

2011-11-23

Abstract:On the basis of rhodamine, a versatile trifunctional chemosensor RP has been synthesized. It can selectively and sensitively recognize Cu(2+) and Zn(2+) in different solutions. Based on the zinc-containing [RP@Zn(2+)] complex, it shows highly selective recognition for His/Cys. Fluorescent imaging of Zn(2+) in living cells was also obtained.
Detection of anti‐type VII collagen IgE antibodies in epidermolysis bullosa acquisita

H. Koga,K. Teye,K. Yamashita,N. Ishii,D. Tsuruta,T. Nakama

DOI: https://doi.org/10.1111/bjd.17310

IF: 11.113

2018-12-27

British Journal of Dermatology

Abstract:Abstract Background Epidermolysis bullosa acquisita (EBA) is a rare pemphigoid disease involving autoantibodies to type VII collagen (COL7), a major structural component of anchoring fibrils. IgE autoantibodies to type XVII collagen (BP180) have been identified in bullous pemphigoid (BP), the prototype of pemphigoid diseases. Although the pathogenic relevance of IgG anti‐COL7 has been investigated, that of IgE in EBA remains unclear.

dermatology
DP15 A rare immunobullous diagnosis in a varicella zoster-naive patient

Kirsty Smith,Christopher Phillips,Sabrina Khan,Nicholas McEntyre,Antonia Lloyd-Lavery

DOI: https://doi.org/10.1093/bjd/ljae090.237

IF: 11.113

2024-06-28

British Journal of Dermatology

Abstract:Abstract We present a rare diagnosis in a 41-year-old man referred urgently from the infectious diseases team with a 3-week history of extensive itchy and painful mucocutaneous blistering and ulceration. This initially affected his hands, spreading to involve his limbs and trunk. His oral and genital mucosae were similarly affected. He reported lethargy and weight loss secondary to reduced oral intake but was otherwise systemically well. He had hypertension managed with amlodipine but he had not recently taken any other medications or supplements. He had emigrated to the UK from Ghana 6 months earlier and no contacts were similarly affected. Examination revealed multiple tense vesicles and bullae with crusted erosions scattered across his trunk and limbs on a background of urticated erythema involving approximately 40% of his body surface area. Haemorrhagic bullae were present on his tongue, his labial and buccal mucosa, and his genital mucosa. He had an extensive infection screen. Of note, viral polymerase chain reaction of vesicular fluid was negative and he was noted to have negative varicella zoster virus (VZV) IgG, in keeping with his history of never previously having chickenpox. Histopathology demonstrated subepidermal blistering with neutrophils and a neutrophil-rich superficial perivascular inflammatory infiltrate and small collections of neutrophils in dermal papillae with incipient clefting. Direct immunofluorescence showed linear deposition of IgG and C3 along the basement membrane zone localizing to the base on salt-split skin. Enzyme-linked immunosorbent assay to collagen VII was strongly positive, and it was negative to BP180/230. On the basis of his clinical findings and investigation results, epidermolysis bullosa acquisita (EBA) was diagnosed. After careful consideration and discussion with the patient, the decision was made to delay systemic immunosuppressive treatment until he had completed VZV vaccination. He was initially managed with clobetasol ointment, Trimovate cream (clobetasone butyrate, nystatin and oxytetracycline calcium) and fluticasone mouthwash. He subsequently commenced prednisolone 40 mg daily, with complete resolution of blistering within 1 month, leaving areas of postinflammatory hypopigmentation, scarring and milia. The introduction of dapsone 50 mg daily has enabled him to gradually wean the dose of prednisolone without further flares. EBA is a very rare immunobullous disease characterized by autoantibodies directed against collagen VII. Different clinical phenotypes are recognized, including a mechanobullous phenotype characterized by acral involvement, skin fragility, scarring and milia; an inflammatory phenotype with skin changes resembling pemphigoid; and a mucosal dominant phenotype. His case was complicated by the need to delay systemic immunosuppression to enable VZV vaccination, an important consideration when long-term immunosuppression may be required. Fortunately, our patient has shown an excellent response to dapsone, highlighting the value of this medication in EBA, among other immunobullous diseases.

dermatology
Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study

Yuexin Zhang,Jingyang Dang,Ruoyu Li,Xixue Chen,Xuejun Zhu,Mingyue Wang

DOI: https://doi.org/10.2340/actadv.v104.11917

2024-01-25

Abstract:Epidermolysis bullosa acquisita (EBA) rarely develops in childhood. This study retrospectively recruited paediatric patients with EBA (age ≤ 16 years), diagnosed by clinical and histopathological features and results of immunofluorescence, immunoblotting and enzyme-linked immunosorbent assay (ELISA), and reviews their clinical manifestations, histopathology, immunological features, and responses to various treatments. All 7 included patients presented with inflammatory EBA. Among them, 3 had a bullous pemphigoid-like phenotype. Pathologically, in addition to dermal–epidermal blistering, in all patients, the distribution of neutrophils was superficial perivascular or interstitial, or in the dermal papilla. Mixed neutrophils and eosinophils were detected in 2 of the 3 patients with bullous pemphigoid-like phenotypes. In addition to treatment with glucocorticoids, dapsone was administered in 4 patients, while thalidomide and sulfasalazine were administered in 1 patient. All patients responded to the these therapies. Relapse was mainly due to reduction and cessation of glucocorticoids. In conclusion, EBA in childhood may be unique, and thus distinct from its adult counterpart. Specific treatment and follow-up protocols are required for therapy of this rare autoimmune skin disease in children.

dermatology
Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane

H. SHIMIZU,J.N. McDONALD,D.B. GUNNER,M.M. BLACK,B. BHOGAL,I.M. LEIGH,P.C. WHITEHEAD,R.A.J. EADY

DOI: https://doi.org/10.1111/j.1365-2133.1990.tb07278.x

IF: 11.113

1990-05-01

British Journal of Dermatology

Abstract:In this study a variety of immunoelectron microscopic methods were used to define the precise ultrastructural binding site of epidermolysis bullosa acquisita antibodies (EBA-Ab). We used two EBA sera which immunoblotted with the same skin-extracted protein as that labelled by a monoclonal antibody (LH7.2) which is known to react with the carboxy terminus of type VII collagen. Gold-conjugated antibodies were used in two different immunoelectron microscopic procedures to compare the labelling characteristics of EBA-Ab and LH7.2 in normal human skin. Antibody incubations were performed using ultra-thin cryosections of unfixed skin and thin slices of fresh skin (en bloc technique) before conventional fixation and embedding in Epon. Both methods showed similar labelling features for both EBA-Ab and LH7.2. With ultra-thin cryosections there was labelling of the lamina densa and an undefined component of the sublamina densa region. With the en bloc technique, labelling of dermal ends of anchoring fibrils and of amorphous material recently defined as 'anchoring plaques' was evident. There was no labelling of the central banded portions of anchoring fibrils. We conclude that EBA-Ag is localized to the dermal ends of anchoring fibrils in addition to the lamina densa and possibly anchoring plaques, and thus has the same distribution as the carboxy terminus of type VII collagen.

dermatology
Autoimmunity against laminin 332

Sabrina Patzelt,Enno Schmidt

DOI: https://doi.org/10.3389/fimmu.2023.1250115

2023-08-10

Abstract:Laminin 332 is a heterotrimeric structural protein of the basal membrane zone (BMZ) of the skin and adjacent mucosal tissues. The importance of laminin 332 for the structural integrity of the BMZ is demonstrated by mutations in any of the three genes encoding for its three chains causing variants of junctional epidermolysis bullosa. Autoimmunity against laminin 332 is observed in mucous membrane pemphigoid (MMP) and in the rare patients with orf-induced pemphigoid. MMP is an autoimmune blistering disease with predominant mucosal manifestations and autoantibodies against the BMZ of the skin and orifice-close mucous membranes. The main autoantigens of MMP are type XVII collagen (BP180) and laminin 332 targeted in about 80% and 10-20% of patients, respectively. An increasing number of studies has highlighted the association of anti-laminin 332 MMP and malignancies that can be revealed in about a quarter of these patients. This data has led to the recommendation of current guidelines to assay for anti-laminin 332 reactivity in all MMP patients. The present review focuses on anti-laminin 332 MMP describing clinical features, its pathophysiology, and detection of serum anti-laminin 332 IgG. In addition, the available data about the occurrence of malignancies in anti-laminin 332 MMP, the underlying tumor entities, and its biology are detailed.
Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies

Wenjing Kuang,Hua Qian,Qiyue Zhang,Wei Li,Takashi Hashimoto,Xin Zeng,Xiaoguang Li

DOI: https://doi.org/10.3389/fimmu.2022.903174

IF: 7.3

2022-06-01

Frontiers in Immunology

Abstract:Mucous membrane pemphigoid (MMP) and anti-laminin (LM) γ1 pemphigoid, two subtypes of subepidermal autoimmune bullous diseases characterized by autoantibodies against epidermal basement membrane zone proteins, mainly show mucosal and skin lesions, respectively. The known autoantigens of MMP includes BP180, BP230, LM332, integrin α6β4 and type VII collagen, and anti-LMγ1 pemphigoid targets LMγ1. In this study, we present an unique MMP case with oral mucosal lesions, which showed positive IgA signals on basement membrane zone in indirect immunofluorescence using normal human skin and on dermal side in indirect immunofluorescence using salt-split skin, positive IgA autoantibodies against LMγ1 by immunoblotting of epidermal extracts, positive IgA autoantibodies against LMα5 by immunoblotting of LM521 recombinant protein (rLM521) and positive IgG autoantibodies against LMγ1 by immunoblotting of rLM111 and rLM521 at first visit (Day 0). After therapy, further serological analyses of serum samples collected at Day 30 and Day 50 indicated that IgA autoantibodies against LMγ1 were likely to be pathogenic. These results suggest that LMγ1 is another autoantigen of MMP, and our patient might be the first reported case of anti-LMγ1 MMP.

immunology
Case report: A case of epidermolysis bullosa acquisita with IgG and IgM anti-basement membrane zone antibodies relapsed after COVID-19 mRNA vaccination

Satoko Minakawa,Yasushi Matsuzaki,Shogo Yao,Chihiro Sagara,Eijiro Akasaka,Hiroshi Koga,Norito Ishii,Takashi Hashimoto,Daisuke Sawamura

DOI: https://doi.org/10.3389/fmed.2023.1093827

IF: 3.9

2023-05-30

Frontiers in Medicine

Abstract:We report a case of autoimmune bullous disease (AIBD) with IgG and IgM autoantibodies against epidermal basement membrane zone (BMZ), which showed recurrence of mucocutaneous lesions after coronavirus disease 2019 (COVID-19) mRNA vaccination. A 20-year-old Japanese woman with a 4-year history of epidermolysis bullosa acquisita (EBA) presented to our clinic. She noticed fever and rash on the same day and visited at our hospital 2 days later. Physical examination revealed blisters, erosions and erythema on the face, shoulder, back, upper arms, and lower lip. A skin biopsy from the forehead showed subepidermal blister. Direct immunofluorescence showed linear depositions of IgG, IgM, and C3c in the epidermal BMZ. By indirect immunofluorescence of 1M NaCl-split normal human skin, circulating IgG autoantibodies were bound to the dermal side of the split at 1:40 serum dilution, and circulating IgM antibodies were bound to the epidermal side of the spilt. After the increase of prednisolone dose to 15 mg/day, the mucocutaneous lesions resolved in a week. The present case is the first case of possible EBA with IgG and IgM anti-BMZ antibodies, in which the mucocutaneous lesions were recurred after COVID-19 mRNA vaccination. Clinicians should be aware that bullous pemphigoid-like AIBDs, including EBA and IgM pemphigoid, might be developed after COVID-19 mRNA vaccination.

medicine, general & internal
Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit

Teruki Dainichi,Hiromichi Takeshita,Yoichi Moroi,Kazunori Urabe,Mariko Yoshida,Yoshiko Hisamatsu,Ayako Komai,Hong Duan,Tetsuya Koga,Takashi Hashimoto,Masutaka Furue

Abstract:Cicatricial pemphigoid (CP) is an autoimmune bullous disease accompanied by mucosal lesions. The majority of patients with CP have autoantibodies against BP180. Anti-laminin 5 (epiligrin) CP is relatively rare. It is known that, in most cases, circulating autoantibodies against laminin 5 in these patients recognize the alpha3 and/or beta3 subunits of this molecule. Here we report a case of anti-laminin 5 CP, which showed IgG autoantibodies against the gamma2 subunit of laminin 5 alone. A 50-year-old woman suffered from skin blistering on the trunk and extremities and severe mucosal lesions in the eyes, oral cavities and laryngopharynx. Despite potent systemic steroids, the mucosal lesions and some parts of the skin lesions persisted. Salazosulfapyridine was of value in controlling the laryngopharyngeal lesions and persistent cutaneous blistering, and cyclophosphamide had definite effects especially on ocular lesions. Anti-laminin 5 autoantibodies became undetectable in serum from the patient after the disease was controlled.
C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita

Christian F. Guerrero-Juarez,Paul Schilf,Jing Li,Maria Paula Zappia,Lei Bao,Payal M. Patel,Jenny Gieseler-Tillmann,Sripriya Murthy,Connor Cole,Maria Sverdlov,Maxim V. Frolov,Takashi Hashimoto,Norito Ishii,Thomas Rülicke,Katja Bieber,Ralf J. Ludwig,Christian D. Sadik,Kyle T. Amber

DOI: https://doi.org/10.3389/fimmu.2023.1266359

IF: 7.3

2023-09-21

Frontiers in Immunology

Abstract:Introduction: Inflammatory epidermolysis bullosa acquisita (EBA) is characterized by a neutrophilic response to anti-type VII collagen (COL7) antibodies resulting in the development of skin inflammation and blistering. The antibody transfer model of EBA closely mirrors this EBA phenotype. Methods: To better understand the changes induced in neutrophils upon recruitment from peripheral blood into lesional skin in EBA, we performed single-cell RNA-sequencing of whole blood and skin dissociate to capture minimally perturbed neutrophils and characterize their transcriptome. Results: Through this approach, we identified clear distinctions between circulating activated neutrophils and intradermal neutrophils. Most strikingly, the gene expression of multiple C-type lectin receptors, which have previously been reported to orchestrate host defense against fungi and select bacteria, were markedly dysregulated. After confirming the upregulation of Clec4n , Clec4d , and Clec4e in experimental EBA as well as in lesional skin from patients with inflammatory EBA, we performed functional studies in globally deficient Clec4e −/− and Clec4d −/− mice as well as in neutrophil-specific Clec4n −/− mice. Deficiency in these genes did not reduce disease in the EBA model. Discussion: Collectively, our results suggest that while the upregulation of Clec4n , Clec4d , and Clec4e is a hallmark of activated dermal neutrophil populations, their individual contribution to the pathogenesis of EBA is dispensable.

immunology

Construction and characterization of region-specific microdissection libraries and single-copy microclones for short arm of human chromosome 2

A case of epidermolysis bullosa acquisita with unusual clinical features

Enabling Workflow-Aware Scheduling on HPC Systems

Brief clinical report on visual reinforcement audiometry with deaf infants.

Resident performance and sleep deprivation: a review.

Childhood epidermolysis bullosa acquisita: Confirmation of diagnosis by skin deficient in Type VII Collagen, enzyme-linked immunosorbent assay, and immunoblotting

[Acquired epidermolysis bullosa with a highly varied clinical picture and successful treatment with mycophenolate mofetil]

Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen

Generalized epidermolysis bullosa acquisita

[Clinical, histopathologic, immunofluorescent and ultrastructural estimation of 2 cases of epidermolysis bullosa acquisita]

Identification of proteins in leaf tissues of white clover using MALDI-TOF mass spectrometry

Versatile trifunctional chemosensor of rhodamine derivative for Zn2+, Cu2+ and His/Cys in aqueous solution and living cells.

Detection of anti‐type VII collagen IgE antibodies in epidermolysis bullosa acquisita

DP15 A rare immunobullous diagnosis in a varicella zoster-naive patient

Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study

Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane

Autoimmunity against laminin 332

Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies

Case report: A case of epidermolysis bullosa acquisita with IgG and IgM anti-basement membrane zone antibodies relapsed after COVID-19 mRNA vaccination

Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit

C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita